In more details, post-menopausal breast cancer women displayed a significant downregulated KLK5 expression profile, with 70.2% of them to be classified as KLK5-negative, compared to the pre-/peri-menopausal ones, of whom only the 40.2% of them were categorized as KLK5-negative. This evidence concerns the gene KLK5 and breast cancer.